Citigroup’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,495
| Closed | -$164K | – | 5675 |
|
|
2023
Q2 | $164K | Hold |
2,495
| – | – | ﹤0.01% | 3989 |
|
|
2023
Q1 | $159K | Hold |
2,495
| – | – | ﹤0.01% | 3851 |
|
|
2022
Q4 | $345K | Buy |
2,495
+495
| +25% | +$69.7K | ﹤0.01% | 3406 |
|
|
2022
Q3 | $253K | Buy |
+2,000
| New | +$226K | ﹤0.01% | 3665 |
|
|
2021
Q1 | – | Sell |
-5,466
| Closed | -$3.06M | – | 6309 |
|
|
2020
Q4 | $3.06M | Sell |
5,466
-1,297
| -19% | -$822K | ﹤0.01% | 2455 |
|
|
2020
Q3 | $4.73M | Buy |
6,763
+1,027
| +18% | +$801K | ﹤0.01% | 1923 |
|
|
2020
Q2 | $4.54M | Buy |
5,736
+278
| +5% | +$210K | ﹤0.01% | 1954 |
|
|
2020
Q1 | $3.25M | Buy |
5,458
+1,181
| +28% | +$1.15M | ﹤0.01% | 2041 |
|
|
2019
Q4 | $4.86M | Sell |
4,277
-1,173
| -22% | -$1.28M | ﹤0.01% | 2051 |
|
|
2019
Q3 | $6.48M | Sell |
5,450
-1,104
| -17% | -$1.69M | 0.01% | 1710 |
|
|
2019
Q2 | $10.8M | Buy |
6,554
+3,095
| +89% | +$5.35M | 0.01% | 1340 |
|
|
2019
Q1 | $7.05M | Buy |
3,459
+317
| +10% | +$558K | 0.01% | 1520 |
|
|
2018
Q4 | $4.04M | Buy |
3,142
+432
| +16% | +$663K | ﹤0.01% | 2010 |
|
|
2018
Q3 | $5.13M | Sell |
2,710
-1,567
| -37% | -$3.24M | ﹤0.01% | 1837 |
|
|
2018
Q2 | $8.7M | Buy |
4,277
+780
| +22% | +$1.78M | 0.01% | 1399 |
|
|
2018
Q1 | $7.74M | Sell |
3,497
-1,042
| -23% | -$2.65M | 0.01% | 1426 |
|
|
2017
Q4 | $10.5M | Buy |
4,539
+509
| +13% | +$1.03M | 0.01% | 1260 |
|
|
2017
Q3 | $7.17M | Buy |
4,030
+147
| +4% | +$205K | 0.01% | 1464 |
|
|
2017
Q2 | $5.28M | Buy |
3,883
+1,397
| +56% | +$1.69M | ﹤0.01% | 1649 |
|
|
2017
Q1 | $2.93M | Sell |
2,486
-3,227
| -56% | -$3.29M | ﹤0.01% | 2121 |
|
|
2016
Q4 | $4.57M | Sell |
5,713
-872
| -13% | -$692K | ﹤0.01% | 1936 |
|
|
2016
Q3 | $5.78M | Buy |
6,585
+108
| +2% | +$78.2K | 0.01% | 1535 |
|
|
2016
Q2 | $3.63M | Buy |
6,477
+1,227
| +23% | +$695K | ﹤0.01% | 1859 |
|
|
2016
Q1 | $2.89M | Sell |
5,250
-1,381
| -21% | -$848K | ﹤0.01% | 2099 |
|
|
2015
Q4 | $5.52M | Buy |
6,631
+2,238
| +51% | +$2.24M | 0.01% | 1615 |
|
|
2015
Q3 | $4.87M | Buy |
4,393
+1,776
| +68% | +$3.24M | ﹤0.01% | 1683 |
|
|
2015
Q2 | $5.71M | Buy |
2,617
+2,578
| +6,610% | +$5.25M | 0.01% | 1630 |
|
|
2015
Q1 | $60K | Buy |
+39
| New | +$51.5K | ﹤0.01% | 5435 |
|
Other funds holding BLUE
Citigroup's BLUE Position: Q2 2025 in Review
Citigroup sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 7,503 shares — an estimated $36.6K sold.
Citigroup first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $42.9M in Q2 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- Citigroup reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- Citigroup sold 7,503 bluebird bio shares in Q2 2025, an estimated $36.6K.
- Citigroup first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
- Citigroup's bluebird bio position peaked at $42.9M in Q2 2018.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.